Inventor · disambiguated record
James Andya
Also filed as: ANDYA JAMES
10 granted patents·10 pending applications·2,333 citations·filing 1996–2022
94Inventor score
Top patents by PatentIndex Score
20 records- 0198US7682609B2Protein formulationGENENTECH INC·Filed 2006·Granted Mar 23, 2010·77 cites·30 claims
- 0298US7060268B2Protein formulationGENENTECH INC·Filed 2003·Granted Jun 13, 2006·208 cites·3 claims
- 0398US6685940B2Protein formulationGENENTECH INC·Filed 2001·Granted Feb 3, 2004·402 cites·15 claims
- 0498US6267958B1Protein formulationGENENTECH INC·Filed 1996·Granted Jul 31, 2001·1.5k cites·47 claims
- 0595US9283273B2Protein formulationANDYA JAMES·Filed 2012·Granted Mar 15, 2016·20 cites·16 claims
- 0695US9017671B2Method of treating cancer with a pharmaceutical formulation comprising a HER2 antibodyGENENTECH INC·Filed 2012·Granted Apr 28, 2015·27 cites·14 claims
- 0795US8372396B2Antibody formulationsGENENTECH INC·Filed 2009·Granted Feb 12, 2013·66 cites·27 claims
- 0893US9180189B2Treating a mammal with a formulation comprising an antibody which binds IgEANDYA JAMES·Filed 2005·Granted Nov 10, 2015·18 cites·4 claims
- 0985US9975957B2Anti-OX40 antibodies and methods of useGENENTECH INC·Filed 2015·Granted May 22, 2018·5 cites·40 claims
- 1080US10730951B2Anti-OX40 antibodies and methods of useGENENTECH INC·Filed 2018·Granted Aug 4, 2020·2 cites·7 claims
- 1179US2023263895A1Antibody formulationsGENENTECH INC·Filed 2022·Application pending·0 cites
- 1269US2020179515A1Antibody formulationsGENENTECH INC·Filed 2020·Application pending·0 cites
- 1366US2021009705A1Anti-ox40 antibodies and methods of useGENENTECH INC·Filed 2020·Application pending·0 cites
- 1465US2018221488A1Antibody formulationsGENENTECH INC·Filed 2018·Application pending·0 cites
- 1560US2019062444A1Combination therapy comprising anti-angiogenesis agents and ox40 binding agonistsGENENTECH INC·Filed 2018·Application pending·0 cites
- 1660US2006088523A1Antibody formulationsGENENTECH INC·Filed 2005·Application pending·0 cites
- 1759US2011236383A1Protein FormulationANDYA JAMES·Filed 2011·Application pending·0 cites
- 1858US2010158899A1Protein formulationGENENTECH INC·Filed 2010·Application pending·0 cites
- 1958US2015196642A1Antibody formulationsGENENTECH INC·Filed 2015·Application pending·0 cites
- 2055US2017015755A1Combination therapy comprising anti-angiogenesis agents and ox40 binding agonistsGENENTECH INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when James Andya files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →